0001846253-23-000085.txt : 20230627
0001846253-23-000085.hdr.sgml : 20230627
20230627175621
ACCESSION NUMBER: 0001846253-23-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230623
FILED AS OF DATE: 20230627
DATE AS OF CHANGE: 20230627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cochran Jennifer R.
CENTRAL INDEX KEY: 0001872349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40720
FILM NUMBER: 231048691
MAIL ADDRESS:
STREET 1: C/O LIGAND PHARMACEUTICALS INC
STREET 2: 3911 SORRENTO VALLEY BOULEVARD, STE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OmniAb, Inc.
CENTRAL INDEX KEY: 0001846253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 600
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-250-7800
MAIL ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 600
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Avista Public Acquisition Corp. II
DATE OF NAME CHANGE: 20210212
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-06-23
0
0001846253
OmniAb, Inc.
OABI
0001872349
Cochran Jennifer R.
5980 HORTON STREET, STE 600
EMERYVILLE
CA
94608
1
0
0
0
0
Common Stock
91190
D
Restricted Stock Units
Common Stock
3792
3792
D
Restricted Stock Units
2023-06-23
4
A
0
20000
0
A
Common Stock
20000
23792
D
Stock Option (right to buy)
4.81
2023-06-23
4
A
0
40000
0
A
2033-06-23
Common Stock
40000
40000
D
The Reporting Person previously reported certain awards of Restricted Stock Units (RSUs) in Table I of Form 4, but has elected to report the RSUs in Table II going
forward. As a result, the total reported in Column 5 of Table I has been updated to subtract 3,792 RSUs outstanding on June 23, 2023.
Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in two equal
annual installments, beginning July 12th, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (A) the
date of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the date of grant.
Each Stock Option shall vest and become exercisable in full on the earlier of (A) the date of the annual meeting of the Company's stockholders next following the grant
date and (B) on the first anniversary of the date of grant.
By: /s/ Charles S. Berkman For: Jennifer R. Cochran
2023-06-27